🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VND
$VNDA
🔒 US EquitiesVanda Pharmaceuticals Inc
AVG HISTORICAL GAP
-1.10%
MAX GAP RECORD
+11.75%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VNDA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VNDA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 28, 2026 Earnings Release 2026-10-28 (AFTER CLOSE (21:00)) |
+11.38%
|
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
-8.84%
|
| May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE) |
-5.78%
|
| Feb 11, 2026 Earnings Release 2026-02-11 (AFTER CLOSE) |
-3.77%
|
| Oct 29, 2025 Earnings Release 2025-10-29 (AFTER CLOSE) |
-7.95%
|
| Jul 31, 2025 Earnings Release 2025-07-31 (BEFORE OPEN) |
-5.14%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+1.14%
|
| Feb 13, 2025 Earnings Release 2025-02-13 (AFTER CLOSE) |
-2.55%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
4.4%
Bullish Gaps (3)
Bearish Gaps (9)
Neutral / Flat (3)
📖 Intelligence Summary
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗